SUV(max) reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma

BACKGROUND: A pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NACRT) ensures long-term survival in esophageal squamous cell carcinoma (ESCC) patients following esophagectomy, but pCR patients are a minority. The aim here was to identify prognostic factors in patients with n...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaki, Yushi, Motoyama, Satoru, Sato, Yusuke, Wakita, Akiyuki, Fujita, Hiromu, Sasaki, Yoshihiro, Imai, Kazuhiro, Minamiya, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035772/
https://www.ncbi.nlm.nih.gov/pubmed/33836789
http://dx.doi.org/10.1186/s12957-021-02208-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035772/
https://www.ncbi.nlm.nih.gov/pubmed/33836789
http://dx.doi.org/10.1186/s12957-021-02208-3

Ejemplares similares